August 2, 2012 — Using a microneedle to inject drugs into the suprachoroidal space may provide a method for drug delivery to the posterior segment of the eye that is less invasive and more targeted ...

According to Liu, his preferred option is faricimab, a fairly new agent that was FDA-approved for wet AMD in 2022. The drug ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million, granting the pharma giant ...

A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can ...

CHICAGO — Specialists are losing money with every intravitreal injection they administer, regardless of the drug being injected, an investigator warns. Each injection we do costs $127.74 — $1.60 for ...

After announcing earlier this week the appointment of Andreas Wallnöfer, PhD, MBA, to its Board of Directors, Optigo ...

Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially treat age-related macular degeneration (AMD) and other eye problems. Macular ...

Bispecific antibody treatments remain a promising treatment for diabetic macular edema (DME), as a new study shows that faricimab was effective and had durable results after a year of real-world ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. Eye creams promise the world, but few get reviewers swearing ...